Clinical Trial Update: A Trial to Compare Nebulized Amphotericin B and Nebulized Normal Saline as Maintenance in Patients With Chronic Pulmonary Aspergillosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nebulized amphotericin B as maintenance therapy versus nebulized saline in chronic pulmonary aspergillosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspergilloma
• Pulmonary Aspergillosis

Drugs mentioned

• Nebulized Amphotericin B (amphotericin B)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Chronic Pulmonary Aspergillosis, CPA | Phase 3 | Status: RECRUITING